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Abstract 
Azotobacter vinelandii is a free-living, nitrogen-fixing bacterium with a branched electron transport chain terminating with two 
terminal oxidases, cytochromes d and o. Cytochrome o is thought o receive its electrons from cytochromes c. The gene encoding 
cytochrome ca has been cloned and sequenced (termed the cycA locus). The deduced amino acid sequence contains a20 residue signaling 
peptide sequence on the N-terminal end. Mutagenesis was performed by inserting a Km r cassette into the structural gene. The subsequent 
mutant strains howed reduced amounts of cytochromes c (approximately 60% of wild-type levels) based on difference absorption spectra 
measurements. Heme staining confirmed the complete loss of cytochrome c 4 protein in the mutant strains. These mutants could grow and 
respire normally, like the wild type, under both diazotrophic or non-diazotrophic conditions. Surprisingly, the cytochrome o terminal 
oxidase was still turning over in membranes from the cycA mutants as evidenced by substrate-reduced CO difference spectra and 
inhibition experiments with the use of the cytochrome o inhibitor, chlorpromazine. Still, the levels of oxidation by ascorbate-TMPD were 
greatly reduced in the cycA mutants. Therefore, it is proposed that cytochrome c 4 does not exist in complex with cytochrome o as a 
multi-component terminal oxidase complex, yet still passes electrons to it in parallel ike cytochrome c 5, as opposed to in an obligate 
sequential manner with cytochrome c 5. In this pathway the proposed new branch is at the ubiquinone to cytochromes c level. 
Keywords: Cytochrome c; Electron transport; Nitrogen fixation; Respiratory protection; (A. vinelandii) 
1. Introduction 
Biological nitrogen fixation, the process by which at- 
mospheric nitrogen is reduced to ammonia, is catalyzed by 
an enzyme system known as nitrogenase. This enzyme 
system, found only in a limited number of prokaryotes, is
sensitive to oxygen and is extremely energy demanding 
(see [1] for a recent review). Because of these unusual 
demands on nitrogenase function, nitrogen-fixing aerobes 
have the unique problem of balancing the levels of intra- 
cellular oxygen to prevent inhibition of nitrogenase while 
carrying out oxygen-dependent respiration to allow for 
ATP synthesis. Thus the electron transport chains of these 
obligate aerobes have a dual role of consuming excess 
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oxygen to protect nitrogenase and conserving energy via 
oxidative phosphorylation. 
A commonly studied aerobic diazotroph is the free-liv- 
ing soil bacterium Azotobacter vinelandii. A. vinelandii 
has a branched electron transport chain which contains 
several f lavin-dependent substrate dehydrogenases, 
ubiquinone Q-8, and at least six spectroscopically de- 
tectable cytochromes of which cytochromes d and o are 
terminal oxidases [2-5]. The branch site, which occurs at 
the quinone level, yields a cytochrome b ~ d and a c ~ o 
terminal pathway, as illustrated in Fig. 1. Cytochrome 
b/d  has been cloned and sequenced [6], and has been 
shown to be up-regulated when n/f genes are transcription- 
ally activated [7]. Mutants with a transposon i serted into 
the structural b/d  gene could not fix nitrogen under air 
(20% oxygen) but could do so under low oxygen (1.5%), 
demonstrating that this pathway is involved in respiratory 
protection of nitrogenase [8]. 
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Fig. 1. The electron transport chain of A. vinelandii. Q8, ubiquinone Q-8; 
Cyt, cytochrome. Adapted from Haddock and Jones [4]. 
encoding this protein and characterizing the subsequent 
mutant strains. 
2. Materials and methods 
2.1. Bacterial strains, plasmids, and growth conditions 
In contrast, the cytochrome c ~ o pathway is thought 
to be involved in energy conservation. A. vinelandii has at 
least four cytochromes c, two major c-types, cytochromes 
c 4 and c 5, as well as two minor c-types, cytochromes 
c-551 and c-555 [9]. The function of the two minor 
cytochromes c is unknown, however the two major c-types 
(c 4 + c 5) are thought o transfer electrons in a sequential 
pathway from ubiquinone (or some unidentified intermedi- 
ate) to the terminal oxidase cytochrome o [2-5]. There 
have been many bacterial and mitochrondrial cytochromes 
c studied and they mostly play roles in donating electrons 
to terminal oxidases [see [ 10,11 ] for a general review]. 
A cytochrome oxidase complex containing cytochromes 
c a and o has been purified from A. vinelandii membranes 
[12]. This complex was found to be able to oxidize ascor- 
bate-N, N, N', N'-tetramethyl-p-phenylenediamine (TMPD) 
and was proposed to be a terminal oxidase complex. More 
recent work on cytochrome c a has concluded that it is not 
involved in ascorbate-TMPD oxidation, nor is it joined in a 
complex with cytochrome o as a terminal oxidase in 
membranes [13]. Thus there appear to be open questions 
on the nature of cytochrome ca in association with other 
cytochromes and therefore on the role of cytochrome c 4 in 
the electron transport chain. This work addresses the role 
of cytochrome c4 by cloning and mutation of the gene 
The bacterial strains and plasmids used in this work are 
listed in Table 1. A. vinelandii strains were grown at 30 ° C 
in Burk's sucrose medium [14] with 2% (w/v )  sucrose 
(BS), supplemented with 25 mM ammonium chloride 
(BSN) as a fixed nitrogen source, when needed. A rich 
modification (RMN) [15] of Burk's sucrose medium sup- 
plemented with ammonium was used in experiments in 
which the cytochrome b /d  deletion was grown. This was 
done for ease of growth of the extremely respiratory 
deficient b/d  mutant. Similar results were obtained when 
strains were grown in minimal Burk's sucrose medium as 
in RMN (unpublished ata). Antibiotics were added at the 
following concentrations: kanamycin, 5 /zg ml - l ;  and 
spectinomycin, 5 /xg ml-~ as needed. Batch cultures for 
isolation of membranes were grown in 2 1 baffled flasks, 
containing 800 ml of medium and shaken vigorously at 
220 rpm in a rotary shaker/incubator. For growth mea- 
surements, 20 ml cultures were shaken in 250 ml side-arm 
flasks at 220 rpm. Cell densities were measured at 540 nm 
with 0.1 optical absorbance unit equivalent o 2.2-107 
cells m1-1 [16]. 
E. coli strain DH5a (Gibco-BRL) used for plasmid 
growth and isolation was grown at 37°C in LB medium 
[17]. Antibiotics were added at the following concentra- 
tions: ampicillin, 200 /zg ml t; kanamycin, 25 /xg ml-1; 
and spectinomycin, 25 /xg ml 1 when required. 
Table 1 
Bacterial strains and plasmids 
Strain/plasmid Description Origin/Reference 
Strain 
Azotobacter vinelandii 
CA 
CA Acyd:: 123 
CAcycA::Kanl 
CAcycA::Kan5 
E. coli 
DH5 a 
Plasmid 
pBluescript KSII( + ) 
pUC4-KIXX 
pAL 1 
pTN1 
pTNl::Kanl 
pTN 1 ::Kan5 
Wild-type strain 
cyd deletion, /2 cassette in the same orientation as the cyd locus 
cycA with Km r cassette inserted in opposite orientation to the cycA gene. 
cycA with Km r cassette inserted in the same orientation as the cycA gene. 
Cloning host 
Ampicillin r
pUC4-K containing the kanamycin-resistance cassette from Tn5 and the bleomycin-resistance gene 
pBluescript KSII( + ) with a 1.76 kb Sall fragment carrying the A. vinelandii cycA locus 
pBluescript KSII( + ) with an approximately 4.0 kb BglII fragment carrying the A. vinelandii cycA 
locus 
pTN 1 with the 1.2 kb Km r cassette from pUC4-KIXX inserted in the opposite orientation of the 
cycA gene within a unique Hpal site in the cycA coding region 
Same as pTNl::Kanl except he Km r cassette is inserted in the same orientation as the o'cA gene 
[33] 
This work 
This work 
This work 
Gibco-BRL 
Stratagene 
[22], Pharmacia 
This work 
This work 
This work 
This work 
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2.2. DNA manipulations 
Genomic DNA from A. vinelandii was prepared by the 
CTAB/NaCI method [18]. All other DNA isolation and 
cloning techniques were performed using standard proce- 
dures [17]. The two degenerate primers used for PCR of 
A. vinelandii genomic DNA each contained a 'GGG' 
clamp sequence and an engineered EcoRI site on the 5' 
end. The N-terminal primer, based on residues 41 through 
49, sequence is 5'-TNAARCARATGCARGAYATH- 
AARGC-3' (384-fold degenerate). The C-terminal primer, 
based on residues 160 though 167, sequence is 5'- 
CATDATCATRTTRTCNCCRTCRTT-3' (192-fold degen- 
erate). Standard reaction conditions for PCR were used 
[17] using 160 pmol of each degenerate primer and 10 ng 
of CA genomic DNA. 30 cycles were done at an annealing 
temperature of 45 ° C for 1 min and extension at 72 ° C for 
95 sec. Southern hybridizations of A. vinelandii genomic 
DNA, phage clones, and plasmid subclones were per- 
formed using established protocols [17]. Probes for South- 
ern blots and library screening were made from gel-puri- 
fied restriction fragments using the Prime-it II kit (Strata- 
gene) and [a-32p]dATP or [a-32p]dCTP (3000 Ci 
mmol-1) (NEN Research Products). 
The A. vinelandii genomic library constructed in lambda 
EMBL3 has been previously described [19]. The library 
was screened with the radiolabelled PCR subclone frag- 
ment using standard protocols [17]. After a secondary 
screen of positive plaques, single phage plaques were 
selected to produce high-titer stocks. Phage DNA was 
isolated from the high-titer stocks and further charac- 
terized. Plasmid pBluescript KSI I (+)  (Stratagene) was 
used for further subcloning. Plasmid pAL1 containing a 
1.76 kb SalI fragment carrying the cycA locus, constructed 
by cloning the gel-purified 1.76 kb SalI fragment from 
phage DNA into the unique SalI site in the polylinker of 
pBluescript KSI I(+),  was used for sequencing. Plasmid 
pTN1, which has an approximately 4.0 kb BgllI fragment 
containing the cycA locus, was constructed by cloning the 
blunted gel-purified 4.0 kb BgllI fragment from phage 
DNA into the unique EcoRV site in the polylinker of 
pBluescript KSI I(+);  thereby losing the BgllI sites. This 
plasmid was used for mutant strain construction (as de- 
scribed below). The orientation of the insert in these two 
plasmids was determined by restriction mapping. 
Plasmid pAL1 and various subclones of it were se- 
quenced using the Sequenase Version 2.0 kit (U.S. Bio- 
chemicals) following the manufacturer's instructions for 
double stranded sequencing or at the DNA Analysis Facil- 
ity of Johns Hopkins University School of Medicine on a 
Applied Biosystems 373a automated DNA sequencer (Ap- 
plied Biosystems) using the fluorescent di-deoxy termina- 
tor method of cycle sequencing following ABI protocols 
[20,21]. DNA and amino acid sequences were analyzed 
using the PC/Gene software package (Intelligenetics). The 
DNA sequence was sequenced and confirmed in both 
strands and has been submitted to the EMBL/Gen- 
Bank/DDBJ Nucleotide Sequence Data Libraries. The 
accession umber is L37290. 
2.3. Construction of A. vinelandii mutants 
The in vitro mutagenesis of cycA was performed by 
cloning the gel-purified Kill r cassette (1.2 kb SmaI frag- 
ment) from plasmid pUC4-KIXX [[22], from Pharmacia] 
into the unique HpaI site in plasmid pTN1. This yielded 
plasmids pTN 1 ::Kan 1 and pTN 1 ::Kan5. The orientation of 
the Km r cassette in pTN 1 ::Kan 1 and pTN 1 ::Kan5 is in the 
opposite and same direction as the disrupted cycA gene, 
respectively, as determined by restriction mapping. Plas- 
mids pTN 1 :: Kan 1 and pTN 1 ::Kan5 were doubled-digested 
with ApaI and EcoRI (to release the insert from the 
pBluescript KSI I (+)  vector) and this linearized DNA was 
used to transform competent A. vinelandii CA cells as 
described below. 
In vitro mutagenesis of the A. vinelandii cytochrome 
b/d  gene was made as follows. Plasmid pAVP1, contain- 
ing a 0.65 kb PstI restriction fragment corresponding to 
the genomic DNA region directly upstream of the cydAB 
locus, which is cloned into the PstI site within the 
polylinker of pBluescript SKI I (+)  [6] was doubled-di- 
gested with EcoRI and XhoI. The 1.3 kb EcoRI-XhoI 
restriction fragment located immediately downstream of 
the cydAB region [see Fig. 2 of [6]] was directionally 
subcloned into these sites yielding plasmid pAcyd. Plas- 
mid pAcyd was linearized at the unique EcoRI site and 
blunted and the 12 cassette (spectinomycin r) from plasmid 
pHP4512 [23] was subcloned into it as a blunted 2.0 kb 
BamHI fragment. This yielded plasmid pAcyd:: 123 which 
contains the 12 cassette in the same orientation as the 
deleted cydAB genes. Correct structure and orientation was 
verified by restriction mapping. This plasmid was lin- 
earized at the unique XhoI site and the DNA was used to 
transform competent A. vinelandii wild-type cells as de- 
scribed below. 
A. vinelandii wild-type strain CA was made competent 
by a simplified modified protocol [24]. After transforma- 
tion and growth on non-selective CM agar medium, cells 
were plated onto either BSN or RMN plates containing the 
appropriate antibiotic. Antibiotic resistant colonies were 
subcultured four times on the appropriate antibiotic plates. 
This yielded the mutant strains: CAcycA::Kanl, 
CAcycA::Kan5, and CAAcyd::123. Mutant strains CA- 
cycA::Kanl and CAcycA::Kan5 have the Kill r cassette in 
the opposite and same direction as the cycA gene respec- 
tively. Mutant strain CA Acyd::123 has the 12 cassette in 
the same direction as the deleted cydAB locus. This cy- 
tochrome b /d  deletion mutant has the same physiological 
characteristics as the previously described cytochrome d
transposon mutant [8]. The genomic organization of the 
desired deletion and/or insertion in the mutant strains 
were confirmed by genomic Southern blots. 
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2.4. Preparation of membranes 
Cells were harvested at late log phase (optical ab- 
sorbance at 540 nm of 0.7-0.9). Whole cells were resus- 
pended in a 50 mM phosphate buffer (pH 7.4) with 2.5 
mM MgC12 and stirred overnight at 4 ° C to remove en- 
dogenous substrates. Membranes were isolated from the 
cell suspension as previously described [25]. 
2.5. Protein determination 
Protein concentrations were determined using the BCA 
protein assay kit (Pierce) with bovine serum albumin as 
the standard. 
2.6. Gel electrophoresis, protein and heme staining 
SDS-polyacrylamide gel electrophoresis (PAGE) and 
Coomassie brilliant blue staining was performed using 
standard methods [17]. Prior to SDS-PAGE, membranes 
were extracted with n-butanol as previously described [26]. 
The single-step artially purified membranes were heated 
with SDS sample buffer that did not contain /3-mercapto- 
ethanol at 90°C for 5 min immediately before elec- 
trophoresis on 12.5% gels. Gels were stained for heme c 
by peroxidase action on 3,3'-dimethoxybenzidine as previ- 
ously described [27]. 
2.7. Whole-cell and membrane respiratory rate measure- 
ments 
For whole-cell respiratory rate measurements, aliquots 
of cultures diluted with medium were transferred into a 
sealed gas-tight, magnetically stirred 8-ml chamber. Respi- 
ratory rates were measured at room temperature with a 
YSI 5331 amperometric oxygen electrode (Yellow Springs 
Instruments). 
Membrane respiratory rates were done at room tempera- 
ture in a 50 mM phosphate buffer (pH 7.4) with 2.5 mM 
MgC12, in the same chamber as described above. The 
reaction was initiated by the addition of the membrane 
samples followed by the substrate. The substrates used 
were 5 mM NADH, 10 mM malate, 20 mM succinate, or 4 
mM ascorbate-2 mM TMPD. The ascorbate-TMPD respi- 
ratory rates were corrected for the small but significant 
auto-oxidation rate of this substrate. For the chlorproma- 
zine inhibition, the same substrates were used, except that 
the membrane samples were preincubated with either 100 
/zM or 500 /zM chlorpromazine for 5 min before addition 
of substrate. The concentration of oxygen in air-saturated 
medium or buffer was taken to be 250 /zM at room 
temperature. 
2.8. Spectroscopic analysis 
Difference spectra were performed at room temperature 
with a Beckman DU-70 spectrophotometer (Beckman In- 
struments). 1.0 ml of membrane samples were placed in a 
semi-micro quartz cuvette with a 10-mm pathlength (Savant 
Instruments) and tightly stoppered with a sleeve type 
rubber stopper to keep the samples anaerobic when neces- 
sary. Membranes were reduced or oxidized with a few 
grains of sodium dithionite or ammonium persulfate, re- 
spectively. To reduce membranes with NADH, the stop- 
pered cuvette containing the membrane samples was 
flushed with argon gas for 2 min to remove oxygen. 5 mM 
NADH was then added and the sample was equilibrated at 
room temperature for 15-20 min with substrate before 
recording spectra. For CO difference spectra, reduced 
membrane samples were flushed with CO for 2 min before 
recording spectra. Two spectral control experiments were 
performed. An inhibitor to the cytochrome o pathway, 
chlorpromazine (at 100 /zM) [39] was used along with 
reductant (5 mM NADH) to document the significance of 
the trough at 558 nm. The cytochrome o trough at 558 nm 
was diminished by chlorpromazine for all samples (wild 
type and all mutants). This result is like that previously 
described for A. vinelandii membranes [39]. To ensure that 
the samples remained reduced after CO bubbling, CO 
difference spectra were recorded at intervals up to 30 rain; 
the spectra were unchanged uring this period. The con- 
centrations of cytochromes were calculated from dithion- 
ite-reduced-minus-persulfate-oxidized difference spectra 
using the following extinction coefficients: total cy- 
tochrome b, 17.5 mM -~ cm- l  (560 -580 rim) [28]; total 
cytochrome c, 17.3 mM ~ cm ~ (551-538 nm) [29]; 
cytochrome d, 7.4 mM i cm ~ (628-607 nm) [30]; and 
cytochrome o, 42.2 mM -l  cm 1 (562-575 nm) [31]. 
3. Results 
3.1. Cloning, sequencing, and analysis c?f the cytochrome 
c 4 gene 
Based on the published amino acid sequence of the 
purified A. vinelandii cytochrome c4 protein [32], two 
degenerate oligonucleotide primers were synthesized corre- 
sponding to areas near the N-terminal and the C-terminal 
ends of the sequence. The N-terminal primer was deduced 
from amino acid residues 41 through 49 and the C-termi- 
nal primer was deduced from residues 160 through 167 
(see Fig. 3 below). A. ~'inelandii wild-type strain CA [33] 
genomic DNA was amplified using these two primers and 
the reaction yielded a product of the expected size (0.38 
kb). This PCR fragment was subcloned and partially se- 
quenced. The translated PCR DNA sequence corresponded 
exactly with the previously published cytochrome c 4 pro- 
tein sequence. This PCR fragment was radiolabelled and 
used to probe various restriction digests on genomic South- 
em blots and a lambda EMBL3 gene bank (data not 
shown). Three different lambda EMBL3 clones were se- 
lected as positive during the library screening and they all 
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Fig. 2. Restriction map of the genomic region containing the A. vinelandii cycA locus. The position and direction of the cycA gene is indicated by an 
arrow below the restriction map. Plasmid pAL1, used for sequencing, contains a 1.76 kb SalI fragment. Plasmid pTNI, used for mutagenesis, contains an 
approximately 4.0 kb BgllI fragment. Plasmids pTNh:Kanl and pTNI ::Kan5 were used for mutant strain construction, as described in Materials and 
methods, and contain a Km r cassette with the orientation of the cassette indicated by the direction of the arrow representing the Km r cassette. Restriction 
endonuclease ites are: B, BgllI; H, Hpal; K, KpnI; N, NcoI; S, Sail; X, XhoI. 
contained a common 1.76 kb SalI restriction fragment, 
which also hybridized in the genomic Southern blots. After 
further estriction mapping, two fragments were subcloned 
from the lambda EMBL3 clones into a plasmid cloning 
vector. These were the 1.76 kb SalI fragment, in plasmid 
pAL1, which was completely sequenced on both strands, 
"RBS" 
GTCGAC~C~CACTTTTCTTGAGCCGTGATTTGGATTAGCTGATG~CAAAGCACTCGTG 61 
M N K A L V -15 
ACTCTGCTGTT~CCCTGGGGATCACCGGCCTTGCCCACGCCGCGGGAGATGCCGCCGCCG 122 
T L L L T L G I T G L A H A A G D A A A  6 
GCC~GGC~GGCGGCCGTCTGCGGCGCCTGCCACGGCCCGGACGGC~CAGCGCGGCCCC 183 
G Q G K A A V C G A C H G P D G N S A A P 2 7  
C~CTTCCCGAAACTGGCCGGCCAGGGCGAGCGCTATCTGCTC~GCAGATGCAGGACATC 244 
N F P K L A G Q G E R Y L L K Q M Q D I  47 
~GGCCGGCACC~GCCGGGCGCTCCCG~GGCAGCGGTCGC~GGTGCTGGAAATGACCG 305 
K A G T K P G A P E G S G R K V L E ~ T  67 
GCATGCTCGAC~CTTCAGCGACCAGGACCTGGCCGACCTCGCCGCCTACTTCACCTCGCA 366 
G M L D N F S D Q D L A D L A A Y F T S Q 8 8  
G~GCCGACCGTCGGCGCAGCCGATCCGC~TTGGTGG~GCCGGCGAGACGCTCTACCGC 427 
K P T V G A A D P Q L V E A G E T L Y R 108 
GGCGGC~GCTGGCCGACGGCATGCCGGCCTGTACCGGTTGCCATTCGCCG~CGGCGAGG 488 
G G K L A D G M P A C T G C H S P N G E 128 
GC~CACCCCGGCCGCCTATCCGCGCCTGAGCGGCCAGCATGCCCAGTACGTTGCC~GCA 549 
G N T P A A Y P R L S G Q H A Q Y V A K Q I 4 9  
GCTCACCGACTTCCGCG~GGCGCGCGCACC~CGATGGCGAC~CATGATCATGCGCTCC 610 
L T D F R E G A R T N D G D N M I M R S I 6 9  
ATCGCCGCCAAGTTGAGC~C~GGACATCGCTGCGATCTCCAGCTACATCCAGGGCCTGC 671 
I A A K L S N K D I A A I S S Y I Q G L 189 
ACTGAGTCCGGCTCGTCGGCGTTGCGAAAAGGGGGGGGGATAGCCGCCCTTTTTCATTGGC 732 
H > < 190 
Fig. 3. Nucleotide sequence and deduced amino acid sequence of the A. vinelandii cycA structural gene. A possible ribosome-binding site ('RBS') is 
underlined. A predicted stem loop structure located downstream of the stop codon is indicated by converging arrows. The numbering system for the protein 
has been kept the same as per the previously published sequence with the initial methionine at position - 20 and position umber 1 at alanine. Amino acid 
residues in italics represent the signaling peptide sequence with the site of cleavage denoted by A. The residues underlined represent either the heme c 
binding motif of C-X-Y-C-H or a methionine predicted to be a sixth ligand. The two sets of residues in bold were used to make the degenerate primers 
used for PCR (see Materials and methods). This sequence data appears in the EMBL/GenBank/DDBJ Nucleotide Sequence Data Libraries under the 
accession umber L37290. 
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and an approximately 4.0 kb BgllI fragment in plasmid 
pTN1 (Fig. 2). 
The relevant portion of the nucleotide sequence as well 
as the deduced amino acid sequence is shown in Fig. 3. 
The structural gene (now referred to as cycA) was readily 
identified as an open reading frame of 210 amino acids by 
comparison to the previously published amino acid se- 
quence. The deduced amino acid sequence has one distinct 
difference, an additional 20 amino acid residues at the 
N-terminal end. These additional residues form a typical 
signal sequence found in proteins which are transported 
through the inner, cytoplasmic membrane to the periplas- 
mic side [34]. A positively charged residue (lysine) is 
followed by a central hydrophobic region and finally a 
polar cleavage region. Even with the addition of 20 
residues, the numbering system for the protein has been 
kept the same as per the previously published protein 
sequence, with the initial methionine at position -20  and 
position number 1 at alanine (Fig. 3). The precursor pro- 
tein has a calculated molecular mass of 21 687 Da and the 
mature protein a calculated molecular mass of 19655 Da. 
Beyond the signal sequence, the deduced amino acid se- 
quence is in exact agreement with the previously described 
sequence including two heme c binding motifs of C-X-Y- 
C-H and two possible sixth heme ligand methionines at 
positions 66 and 167 [35]. The nucleotide sequence also 
contains a possible ribosome-binding site preceding the 
initiation codon and a ! 0 bp inverted repeat following the 
termination codon (Fig. 3). This inverted repeat may form 
a stem-loop structure in the mRNA containing a stem of 
10 bp with a calculated free energy value of -19.2 kcal 
and may act as a rho-independent terminator. 
Further sequence analysis of areas immediately up- 
stream and downstream of the cycA locus did not reveal 
any other possible open reading frames, including ones 
encoding other cytochromes c. Comparisons of the amino 
acid sequence of A. r'inelandii cytochrome c 4 with other 
bacterial cytochromes c, including c 4 and c-551, have 
been previously reported [35-37]. Recently, a nucleotide 
sequence for a cytochrome c 4 has been published from 
Pseudomonas stutzeri [38]. There is 79% identity between 
the mature protein sequences of A. vinelandii cytochrome 
c 4 and P. stutzeri cytochrome c 4, and 85% identity be- 
tween their signaling peptide sequences. 
3.2. Construction of a cycA Km r insertional mutant in A. 
~,inelandii 
Plasmid pTN1 contains the complete structural gene of 
cytochrome c a as well as enough flanking DNA to allow 
for recombination events on both sides of the gene. The 
cycA gene has an unique HpaI site within the sequence. A 
kanamycin-resistance cassette (Km r) was inserted into the 
HpaI site in both orientations (i.e. in the same direction as 
the cvcA gene and in the opposite direction) in plasmid 
pTNI. These plasmids are designated as pTNl::Kanl and 
pTNl::Kan5 (Fig. 2). Linearized gel-purified restriction 
fragments from these two plasmids containing the insertion 
were transformed into competent A. uinelandii wild-type 
strain CA. After an incubation period to allow for homolo- 
kDa 
71.0  m 
41.8  - - -  
30.6  m 
cytochrome c 4 
17 .8  - - -  
A B 
12 34  1 2 34  
Fig. 4. A. SDS-PAGE of n-butanol extracted, partially purified membranes from strains of A. vinelandii on 12.5% polyacrylamide g ls. Approximately 85 
/xg of membrane proteins were loaded in each lane after being heated with SDS sample buffer (w/o  fl-mercaptoethanol) at 90 ° C for 5 min. 5/xg of horse 
heart cytochrome c was used as a control. The gel was stained for heme with 3,3'-dimethoxybenzidine. Lanes: 1, CA; 2, CAcycA::Kanl; 3, 
CAcycA::Kan5; 4, horse heart cytochrome c. B. An identically loaded gel as in panel A stained for total protein using Coomassie brilliant blue. 
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gous recombination, transformants were selected for 
kanamycin resistance, and subcultured several times on 
kanamycin- and ammonium-supplemented agar plates to 
allow for selection of pure colonies. This yielded the 
mutant strains CA cycA::Kan 1and CA cycA::Kan5 with the 
Km r cassette inserted in the opposite orientation and same 
orientation as the cycA gene, respectively. The genomic 
DNA from these mutants as well as from wild-type cells 
were probed with both the Km r cassette and a fragment of 
the cycA structural gene in Southern blots, demonstrating 
that indeed the Km r cassette was present in the mutants 
and not in the wild type and the cycA gene was disrupted 
in the mutants and not in the wild type (data not shown). 
CA had a rate of 157_  9, CAcycA::Kanl and 
CAcycA::Kan5 had rates of 146 __+ 8 and 146 _ 18, respec- 
tively. As a control for the effect of the lack of the b /d  
oxidase pathway a deletion strain CA Acyd:: g23 (described 
in Materials and methods) was also used. This mutant had 
the same phenotype as a previously described cytochrome 
d mutant [8]. It had an oxygen consumption rate of 24 + 2. 
3.5. Spectral analysis of mutants 
Room-temperature dithionite-reduced-minus-persulf- 
ate-oxidized ifference spectra of membranes from wild- 
type CA cells demonstrated total cytochrome d (peak at 
3.3. Heme staining of the cycA mutants 
To investigate whether the Km f insertional mutagenesis 
had resulted in a null mutation of the cycA gene, SDS- 
polyacrylamide g l electrophoresis and heme staining were 
performed. Membranes, isolated from both the wild-type 
and mutant strains, were treated with n-butanol as de- 
scribed in Materials and methods; this results in a partial 
purification of c-type cytochromes [26]. As seen in Fig. 
4A (heme stain) only the wild-type lane contained cy- 
tochrome c4 while both of the mutants CA cycA::Kan 1and 
CAcycA::Kan5 had no traces of the protein. Coomassie 
brilliant blue staining of an identically loaded gel confirms 
that approximately the same amount of protein was loaded 
in each lane (Fig. 4B). Additionally, the apparent molecu- 
lar weight of the heme stained product corresponds very 
well with the calculated molecular mass of the mature 
protein (19 655 Da) and with those reported previously on 
purified A. vinelandii cytochrome c a [26]. 
3.4. Growth and nitrogen fixing ability of the cycA mutants 
Growth of the cycA mutants was not affected whether 
the cells were starved of oxygen or of fixed nitrogen. In 
fact, wild-type and cycA mutants had similar doubling 
times in either Burk's sucrose medium supplemented with 
ammonium or in ammonium-free medium. During dia- 
zotrophic growth conditions, the wild type (CA) doubled 
every 4.2 h while CAcycA::Kanl doubled every 4.3 h and 
CAcycA::Kan5 doubled every 3.8 h. Similar results were 
found during non-diazotrophic growth conditions with CA 
doubling every 5.0 h, CAcycA::Kanl doubling every 5.4 
h, and CAcycA::Kan5 doubling every 5.4 h. To further test 
the similarities in growth of the cycA mutants with the 
wild type, whole cell respiration assays were performed 
using standard Burk's medium with sucrose as the sole 
carbon source. When grown in ammonium-free medium, 
the oxygen consumption rates (in nmol 02 min- '  108 
cells -] -4-standard eviation) were: CA, 212 ___ 21; CA- 
cycA::Kanl, 219 + 14; and CAcycA::Kan5, 220___ 14. In 
ammonium-supplemented m ium, respiratory rates for all 
the strains was less than in ammonium-free medium; strain 
551 
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Fig. 5. Room-temperature dithionite-reduced-minus-persulfate-oxidized 
difference spectra of membranes isolated from strains of A. vinelandii. 
The membrane protein concentrations were as follows: CA, 10.44 mg 
ml-t ;  CAAcyd::123, 13.00 mg ml- I ;  CAcycA::Kanl, 13.05 mg ml- I ;  
CAcycA::Kan5, 11.22 mg ml - ' .  The position of the absorption maxi- 
mum of different peaks are indicated in nm. The absorption scales are 
shown as optical density units (AA). 
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627 nm), b (shoulder at 559 nm), and c (peak at 551 rim) 
as described previously [25] (Fig. 5). As expected, the 
cytochrome b /d  deletion lacks a peak at 627 nm and the 
shoulder at 559 nm has been reduced, showing the loss of 
heme d and reduced amount of heme b. The cycA mutants 
CA cycA::Kan 1 and CA cycA::Kan5 had identical spectra, 
with the peak at 551 nm reduced to a shoulder in compari- 
son to the wild type, and a peak at 559 nm, where the wild 
type exhibits only a shoulder (Fig. 5). These spectra 
clearly demonstrate a significant reduction in the total 
amount of c-type cytochromes in the cycA mutants. 
Cytochrome concentrations were calculated based on 
the reduced-minus-oxidized difference spectra s shown in 
Table 2. Cytochrome content was found to be very similar 
between the wild-type and the cycA mutants except for the 
amounts of cytochromes c. There is an approximate 60% 
loss of cytochromes c in the cycA mutant strains. Once 
again, as expected there was no detectable amounts of 
cytochrome d in the cytochrome b/d deletion mutant. 
Room-temperature (CO + reduced)-minus-reduced dif- 
ference spectra, using either dithionite or the physiological 
Table 2 
Cytochrome concentration i membranes i olated from different strains of 
A. c, inelandii 
Strain a Concentration ( mol mg protein i) b of cytochrome 
Total b Total c d o 
CA 0.860 1.04 0.181 0.291 
CA Acyd::/23 0.782 1.29 ND c 0.248 
CAcycA::Kanl 0.719 0.601 0.138 0.246 
CAcycA::Kan5 0.807 0.626 0.141 0.281 
a Cultures of A. t~inelandii were grown in RMN with added antibiotic 
where appropriate and membranes were isolated as described in Materials 
and methods. 
b Cytochrome concentrations were determined by reduced-minus-oxidized 
difference spectroscopy using extinction coefficients as described in 
Materials and methods. 
c ND, not detected, 
substrate NADH as reductant, was also performed (Fig. 6). 
Dithionite and NADH each reduced cytochromes o and d 
as seen by troughs at 558 nm and 624 nm, respectively in
wild-type membranes, as seen previously [25]. The cy- 
~.=0.1 
~ -- + DidlJoniz 
CA 
+ NADH 
+ NADH 
+ NADH 
~ + i~aiaaim 
CAcycA::Kan5 
+ NADH 
! 
624 
I I I I I I 
450 J00 550 (300 650 71111 
W A ~  (~m) 
Fig. 6. Room-temperature CO difference spectra of dithionite- and NADH-reduced membranes isolated from strains of A. •,inelandii. The membrane 
protein concentrations are the same as in Fig. 4. The position of the absorption minimum of different roughs are indicated in nm, and the absorption scale 
is shown as optical density units (AA). 
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Table 3 
Respiration rates from membranes i olated from different strains of A. L'inelandii 
127 
Substrate a Respiration rates (nmol min- i mg protein- ~ ) b of A. L, inelandii strains c (% inhibition with chlorpromazine) d 
CA CA A cyd:: J2 3 CA cycA ::Kan I CA cycA ::Kan5 
NADH 444 + 36 (68) 123 _ 12 538 + 17 (71) 540 + 34 (73) 
Malate 597 + 62 (74) 159 _ 12 360 + 18 (67) 360 + 15 (69) 
Succinate 199 + 22 (71) 42 ± 5 201 + 12 (60) 210 + 8 (70) 
Ascorbate-TMPD 1895 _ 149 (64) 1878 ± 143 301 ± 20 (60) 438 ± 17 (60) 
The substrates were 5 mM NADH, 10 mM malate, 20 mM succinate, or 4 mM ascorbate-2 mM TMPD. 
h The respiratory rates shown were determined amperometrically using an oxygen electrode. Each value is a mean + standard eviation of the values 
obtained from four separate determinations. 
c Cultures of A. uinelandii were grown and membranes were isolated as described in Table 2. 
d Membranes were preincubated with chlorpromazine for 5 rain (w/o  substrate) and then the assay was initiated with the addition of substrate. 100 /zM 
chlorpromazine was used with all substrates xcept for ascorbate-TMPD when 500 /xM was added. 
tochrome d mutant lacked the trough at 624 nm but still 
had the trough at 558 nm using either substrate as a 
reductant, demonstrating the lack of the cytochrome b /d  
terminal oxidase (Fig. 6). Surprisingly, the two cycA mu- 
tants exhibited spectra identical to the wild type. Both 
cytochromes o and d were still reduced in the mutants, as 
evidenced by the troughs at 558 nm and 624 nm, when 
using either dithionite or NADH as a reductant (Fig. 6). 
Notably, the amount of cytochrome o reduced by NADH 
in the mutants was essentially indistinguishable from that 
in the wild type. Therefore, cytochrome o is still active as 
a terminal oxidase in the cycA mutants. 
3.6. Oxygen uptake rates and inhibition by chlorpromazine 
Respiratory rates were determined for membranes from 
CA, CA Acyd::~23, CAcycA::Kanl, and CAcycA::Kan5 
using various physiological substrates and the artificial 
electron donor ascorbate-TMPD (Table 3). Oxygen uptake 
rates with the different physiological substrates were simi- 
lar for the wild-type and both cycA mutants. However, the 
respiratory rate with ascorbate-TMPD was significantly 
lower in the cycA mutants as compared to the wild type. 
Chlorpromazine has been previously shown to inhibit the 
cytochrome c ~ o pathway of A. vinelandii membranes 
[39]. The percent inhibition by chlorpromazine of the cycA 
mutants was similar to that of the wild type (ranging from 
60% to 74%), suggesting that cytochrome o is still func- 
tioning as a terminal oxidase in the cytochrome c 4 mu- 
tants. As seen previously, the cytochrome d deletion strain 
had much lower respiratory rates with the physiological 
substrates compared to the wild type; however, it had 
oxygen uptake rates with ascorbate-TMPD like the wild 
type, indicating that the cytochrome c ~ o pathway was 
functioning normally. 
4. Discussion 
Many components in the electron transport chain of A. 
uinelandii have been identified and studied previously, 
leading to a proposed complex branched scheme of elec- 
tron transport [4,5]. However, the genes encoding most of 
these components have not been cloned, thus well defined 
structural gene mutants have not been constructed to un- 
ambiguously determine the function of these components. 
The exception is the cytochrome b/d  terminal oxidase 
complex, which has been well characterized [6-8]. Mu- 
tants in the cytochrome c ~ o pathway have been previ- 
ously reported [40-42]. However, these mutants were made 
with the powerful mutagen N-methyl-N'-nitro-N-nitro- 
soguanidine and thus the precise location of the mutation 
could not be localized. Furthermore, the reported mutants 
contained multiple defects. The report here describes the 
results of cloning the cycA gene and creation of a well 
defined structural gene mutant in cytochrome c 4. 
Not surprisingly, the deduced amino acid sequence 
based on the DNA sequence matched exactly with the 
previously published sequence based on amino acid se- 
quencing of the purified protein [32]. As expected, a 20 
amino acid residue signaling peptide sequence was discov- 
ered, since it had been previously shown that cytochrome 
c 4 is membrane bound but faces the periplasmic side of the 
membrane [13,26]; thus this provides the mechanism by 
which to transport he protein through the hydrophobic 
inner, cytoplasmic membrane. The residues of the signal 
sequence meet all the requirements of a typical signaling 
peptide sequence [34]. Based on the determined nucleotide 
sequence, it appears that the cytochrome c 4 gene is con- 
tained in a single operon without any other co-transcribed 
genes; no other apparent open reading frames were identi- 
fied nearby, and a termination stem-loop structure fol- 
lowed the stop codon. 
Spectrally, it appears that the amount of cytochromes c 
in the cycA mutants is reduced approximately 60% as 
compared to the wild type. Heme staining confirmed the 
loss of cytochrome c z in the mutant strains. Interestingly, 
the mutants were still able to reduce cytochrome o with 
NADH as shown by CO difference spectra using that 
physiological substrate as the reductant. Therefore, it is 
concluded that cytochrome c 4 is probably not situated in 
complex with cytochrome o as a multi-component term±- 
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Fig. 7. Revised diagram of the electron transport chain of A. vinelandii 
incorporating the proposed additional branch at Qs. Qs, ubiquinone Q-8; 
Cyt, cytochrome. 
nal oxidase complex. However, it is still independently 
involved in transferring electrons to cytochrome o. Mu- 
tants lacking cytochrome c a have normal respiratory abil- 
ity with physiological substrates but have greatly reduced 
levels of ascorbate-TMPD oxidation rates. The oxidation 
of the artificial electron donor ascorbate-TMPD has been 
shown to proceed through c-type cytochromes to the cy- 
tochrome o terminal oxidase [43,44]. The percent inhibi- 
tion of oxygen uptake by chlorpromazine was similar in 
the cycA mutants as the wild type, demonstrating that 
cytochrome o is active in the mutants. It was shown 
previously that chlorpromazine inhibits only the cy- 
tochrome c ~ o pathway [39]. 
Based on the evidence that cytochrome o is still turning 
over in a cytochrome c a deleted mutant, a new path of 
electron flow is proposed whereby electrons flow in paral- 
lel from ubiquinone to cytochrome c 4 to cytochrome o
and separately from ubiquinone to cytochrome c 5 to cy- 
tochrome o (Fig. 7) but not in an obligate sequence of 
ubiquinone to cytochromes c 4 c5 to cytochrome o as previ- 
ously thought [2-5]. A similar parallel scheme has been 
previously proposed [45], however their conclusion was 
based on the assumption that exogenous A. vinelandii 
cytochromes c 4 and c 5 donate lectrons to endogenous c 4 
and c 5, respectively. The current work gives further evi- 
dence for this proposed new branch with genetic and in 
vivo physiological data. 
The proposed new separate but parallel c-type electron 
flow pathway may explain the lack of growth differences 
between the cycA mutants and the wild type. It has been 
proposed that there are three sites of proton translocation 
in the electron transport chain of A. vinelandii, at the 
NADH dehydrogenase ite, at the ubiquinone site, and at 
the cytochrome o terminal oxidase site [4,5]. However, 
there is evidence that of the terminal pathways, only the 
cytochrome c 5 to o pathway is coupled to ATP synthesis 
[45]. Therefore the cytochrome c 4 to o pathway may be 
another fast-respiring but non-phosphorylating pathway, 
consuming excess oxygen to protect nitrogenase, like the 
cytochrome b/d  branch [8]. Additionally, cytochromes c 
mutants may be lacking only one of the three proposed 
proton translocation sites while the other two function 
normally; then we could expect a cytochromes c mutant o 
have growth similarities to the wild type. 
Recently, an A. vinelandii mutant has been constructed 
in the terminal oxidase cytochrome o [46]. This mutant 
was identical to the cycA mutants in its ability to fix 
nitrogen in air and its lack of any apparent growth differ- 
ences from the wild type. However, this work was based 
on mutagenesis of a PCR fragment amplified from A. 
vinelandii genomic DNA. Presumably, work is underway 
to clone the genomic region corresponding to cytochrome 
o and the performance of physiological nalyses on subse- 
quent mutant strains. 
Thus far a portion of the sequential cytochrome c ~ o 
pathway in A. vinelandii has been elucidated, but much 
work needs to be done to completely determine the nature 
and function of this pathway. It would be of great interest 
to determine the role of cytochrome c 5 by similar meth- 
ods. Further investigations are needed to study the role of 
respiration and its relationship with nitrogen fixation. 
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